Study of the relationship between adiponectin, interleukin-18, ghrelin and bone mineral density in morbidly obese women after gastric bypass;Estudio de la relación entre las concentraciones plasmáticas de adiponectina, interleucina 18 y ghrelina y la densidad mineral ósea en mujeres con obesidad mórbida tras bypass gástrico

Endocrinologia y Nutricion

Volumn 56, Issue 7, 2009, Pages 355-360

  Vilarrasa, Núria ^a   Gómez, José Manuel ^a   Masdevall, Carles ^a   Pujol, Jordi ^a   Soler, Juan ^a   Elio, Iñaki ^a   Gallart, Lluis ^b   Vendrell, Joan ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Adipocytokines; Adipose tissue; Bone metabolism; Densitometry; Dual energy X ray absorptiometry; Obesity

Indexed keywords

ADIPONECTIN; GHRELIN; INTERLEUKIN 18; PARATHYROID HORMONE; SOMATOMEDIN; VITAMIN D;

ADULT; ARTICLE; BARIATRIC SURGERY; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; OBESITY; STOMACH BYPASS; SURGICAL TECHNIQUE;

ADIPONECTIN; BONE DENSITY; FEMALE; GASTRIC BYPASS; GHRELIN; HUMANS; INTERLEUKIN-18; MIDDLE AGED; OBESITY, MORBID;

EID: 70350449597     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(09)72454-4     Document Type: Article

References (45)

1. Ravn P., Cizza G., Bjarnason N.H., Thompson D., Daley M., Wasnich R.D., et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 14 (1999) 1622-1627
2. Tremollieres F.A., Pouilles J.M., and Robot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 77 (1993) 683-686
3. Kleerekoper M., Nelson D.A., Peterson E.L., Wilson P.S., Jacobsen G., and Longcope C. Body composition and gonadal steroids in older white and black women. J Clin Endocrinol Metab 79 (1994) 775-779
4. Reid I., Evans M., Cooper G., Ames R., and Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 265 (1993) 293-297
5. Gómez J.M. Sex and age differences in serum leptin, insulin-like growth factor-I components and sex-hormone binding globulin in a healthy population. Prot Pept Lett 14 (2007) 708-711
6. Gómez J.M., Maravall F.J., Gómez N., Navarro M.A., Casmitjana R., and Soler J. The IGF-I system component concentration that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res 14 (2004) 91-96
7. Karsenty G. Leptin controls bone formation through a hypothalamic relay. Recent Prog Horm Res 56 (2001) 401-415
8. Gómez-Ambrosi J., Rodríguez A., Catalán V., and Frühbeck G. The bone-adipose axis in obesity and weight loss. Obes Surg 18 (2008) 1134-1143
9. Gómez J.M., Vilarrasa N., Masdevall C., Pujol J., Solano E., Soler J., et al. Regulation of bone mineral density in morbidly obese women: A cross-sectional study in two cohorts before and after bypass surgery. Obes Surg 19 (2009) 345-350
10. Tsao T.S., Murrey H.E., Hug C., Lee D.H., and Lodish H.F. Oligomerization state-dependent activation of NF-Kappa B signalling pathway by adipocyte complement-related protein of 30 kDa (Acrp 30). J Biol Chem 277 (2002) 29359-29362
11. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signalling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
12. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., and Sugimoto T. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 160 (2009) 265-273
13. Jürimäe J., and Jürimäe T. Adiponectin is a predictor of bone mineral density in middle aged premenopausal women. Osteoporos Int 18 (2007) 1253-1259
14. Oh K.W., Lee W.Y., Rhee E.J., Baek K.H., Yoon K.H., Kang M.I., et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 63 (2005) 131-138
15. Kontogianni M.D., Dafni U.G., Routsias J.G., and Skopouli F.N. Blood leptin and adiponectin as posible mediators of the relation between fat and BMD in perimenopausal women. J Bone Miner Res 19 (2004) 546-551
16. Sambrook P. Tumor necrosis factor blockade and the risk of osteoporosis: back to the future. Arthritis Res Ther 9 (2007) 107
17. Quinn JM, Saleh H. Modulation of osteoclast function in bone by the inmune system. Mol Cell Endocrinol. 2009 [en prensa].
18. Maccarinelli G., Sibilia V., Torsillo A., Raimondo F., Pitto M., Giustina A., et al. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 184 (2005) 249-256
19. Fukushima N., Hanada R., Teranishi H., Fukue Y., Tachibana T., Ishikawa H., et al. Ghrelin directly regulates bone formation. J Bone Miner Res 20 (2005) 790-798
20. Misra M., Millar K., Stewart V., Hunter E., Kuo K., Hergoz D.B., et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 90 (2005) 5082-5087
21. Weiss L.A., Langenberg C., and Vaharte-Connor E. Ghrelin and bone: is there an association in older adults?: the Rancho Bernardo study. J Bone Miner Res 21 (2006) 752-757
22. Capella R.F., and Capella J.F. Reducing early technical complications in gastric by-pass surgery. Obes Surg 7 (1997) 149-157
23. Obesity: preventing and managing the global epidemic. Report on a WHO consultation on obesity. WHO/NUT/NCD/98.1 (1997), WHO, Geneva
24. Lenchik L., Register T.C., Hsu F.C., Lohman K., Nicklas B.J., Freedman B.I., et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33 (2003) 646-651
25. Jürimäe J., Jürimäe T., Leppik A., and Kums T. The influence of ghrelin, adiponectin and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 26 (2008) 618-623
26. Jürimäe J., Kums T., and Jürimäe T. Adipocytokine and ghrelin levels in relation to bone mineral density in physically active older women: longitudinal associations. Eur J Endocrinol 160 (2009) 381-385
27. Gonnelli S., Caffarelli C., Del Santo K., Cadirni A., Guerriero C., Lucani B., et al. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 83 (2008) 55-60
28. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., and Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70 (1998) 281-312
29. Kawase Y., Hocino T., Yolota K., Kuzuhara A., Nakamua M., Maeda Y., et al. Bone malformations in interleukin-18 transgenic mice. J Bone Miner Res 18 (2003) 975-983
30. Raggatt L.J., Qin L., Tamasi J., Jefcoat Jr. S.C., Shimizu E., Selvamurugan N., et al. Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions. J Biol Chem 283 (2008) 6790-6798
31. Kojima M., and Kangawa K. Ghrelin: structure and function. Physiol Rev 85 (2005) 495-522
32. Makovey J., Naganathan V., Seibel M., and Sambrook P. Gender differences in plasma ghrelin and its relations to body composition and bone -an opposite sex twin study. Clin Endocrinol (Oxf.) 66 (2007) 530-537
33. Bell N.H., Epstein S., Greene A., Shary J., Oexmann M.J., and Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76 (1985) 370-373
34. Liel Y., Ulmer E., Shary J., Hollis B.W., and Bell N.H. Low circulating vitamin D in obesity. Calcif Tissue Int 43 (1988) 199-201
35. Buffington C., Walker B., Cowan G.S., and Scruggs D. Vitamin D deficiency in the morbidly obese. Obes Surg 3 (1993) 421-424
36. Parikh S.J., Edelman M., Uwaifo G.I., Freedman R.J., Semega-Janneh M., Reynolds J., et al. The relationship between obesity and serum 1,25-dihidroxyvitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89 (2004) 1196-1199
37. Arunabh S., Pollack S., Yeh J., and Aloia J.F. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88 (2003) 157-161
38. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
39. Snijder M.B., Van Dam R.M., Visser M., Deeg D.J., Dekker J.M., Bouter L.M., et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90 (2005) 4119-4123
40. Looker A.C. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab 90 (2005) 635-640
41. Vilarrasa N., Maravall J., Estepa A., Sánchez R., Masdevall C., Navarro M.A., et al. Low 25-hydroxivitamin D concentrations in obese women: Their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 30 (2007) 653-658
42. Makovey J., Naganathan V., and Sambrook P. Gender differences in relationships between body composition components, their distribution and bone mineral density: a cross-sectional opposite sex twin study. Osteoporos Int 16 (2005) 1495-1505
43. Proctor D.N., Melton L.J., Khosla S., Crowson C.S., O'Connor M.K., and Riggs B.L. Relative influence of physical activity, muscle mass and strength on bone density. Osteoporos Int 11 (2000) 944-952
44. Kerr D.A., Papalia S., Morton A., Dick I., Dhaliwal S., and Prince R.L. Bone mass in young women is dependent on lean body mass. J Clin Densitom 10 (2007) 319-326
45. Vilarrasa N., Gómez J.M., Elío I., Gómez Vaquero C., Masdevall C., Pujol J., et al. Evaluation of bone disease in morbidily obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg (2009) May 2 [Epub ahead of print]